LICENSE AGREEMENTLicense Agreement • March 1st, 2010 • Allos Therapeutics Inc • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT, dated as of December 23, 2002, ("Agreement"), is entered into between SRI INTERNATIONAL, a California not-for-profit corporation, having a place of business located at 333 Ravenswood Avenue, Menlo Park, California 94025 ("SRI"), SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH, a New York not-for-profit corporation having a place of business located at 1275 York Avenue, New York, New York 10021 ("SKI"), SOUTHERN RESEARCH INSTITUTE, an Alabama not-for-profit corporation, having a place of business located at 2000 Ninth Avenue South, P.O. Box 55305, Birmingham, Alabama 35255-5305 ("SoRI") (collectively, the "Licensor") and ALLOS THERAPEUTICS, INC., a Delaware corporation, having a place of business located at 11080 Circle Point Road, Suite 200, Westminster, Colorado 80020 ("Allos").
SECOND AMENDMENT TO LICENSE AGREEMENTLicense Agreement • March 1st, 2010 • Allos Therapeutics Inc • Pharmaceutical preparations
This SECOND AMENDMENT TO LICENSE AGREEMENT (this "Second Amendment"), dated as of November 6 2007, is entered into between SRI INTERNATIONAL, a California not-for-profit corporation ("SRI"), SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH, a New York not-for-profit corporation ("SKI"), SOUTHERN RESEARCH INSTITUTE, an Alabama not-for-profit corporation ("SoRI" and, together with SRI and SKI, the "Licensor"), and ALLOS THERAPEUTICS, INC., a Delaware corporation ("Allos"). Allos and Licensor are each sometimes individually referred to herein as a "Party" and collectively as the "Parties."
